<--- Back to Details
First PageDocument Content
Microbiology / Alcohol abuse / Bacteriology / Digestive system / Gut flora / Cirrhosis / Spontaneous bacterial peritonitis / Ascites / CD14 / Medicine / Biology / Bacteria
Microbiology
Alcohol abuse
Bacteriology
Digestive system
Gut flora
Cirrhosis
Spontaneous bacterial peritonitis
Ascites
CD14
Medicine
Biology
Bacteria

An upper limit for macromolecular crowding effects

Add to Reading List

Source URL: www.ncbi.nlm.nih.gov

Download Document from Source Website

File Size: 1,46 MB

Share Document on Facebook

Similar Documents

Economy / Business / Entrepreneurship / Venture capital / Ascites

Press Release Sequana Medical AG raises CHF 23 million in a Series C financing led by LSP, and adds an Independent Board Chairman and Vice President of Sales and Marketing. Zurich, SWITZERLAND - 28 April 2014

DocID: 1rcGW - View Document

Press Release ® Sequana Medical receives CE-mark approval for the use of its alfapump system in cancer patients with malignant ascites Zürich, SWITZERLAND – 30. Oct, 2012

DocID: 1gPDh - View Document

Membrane technology / Peritoneal dialysis / Dialysis / Hemodialysis / Geriatric nephrology / Ascites / Comorbidity / Kidney / Geriatrics / Medicine / Renal dialysis / Nephrology

Microsoft PowerPoint - PD_in_Special_Populations

DocID: 1gE0h - View Document

Hepatocellular carcinoma / Spontaneous bacterial peritonitis / Liver transplantation / Ascites / Hepatorenal syndrome / Prognosis / Medicine / Hepatology / Cirrhosis

Editorial The clinical course of cirrhosis. Population based studies and the need of personalized medicine Gennaro D’Amico Ospedale V Cervello, Palermo, Italy

DocID: 1gBX1 - View Document

Abdomen / Peritonitis / Bowel obstruction / Peritoneal dialysis / Ascites / Peritoneum / Dialysis / Peritoneal mesothelioma / Medicine / Health / Medical emergencies

Microsoft PowerPoint - Encapsulating Peritoneal Sclerosis Hansson April 2011

DocID: 1gj5v - View Document